Disclaimer & terms / Privacy policy

🧾 Disclaimer & Terms of Use (Beta Version)

Article 1 (Purpose and Scope of Application)

This app "Chat-based Medicine Consultation Tool" (hereinafter referred to as "this app") is a system that provides reference information for over-the-counter medicines based on symptoms. It is currently released as a limited beta test for testers only and is not an official medical service. By using this app, users are deemed to have agreed to these terms.

These terms govern use of this app (the service). The source code of this app is not public. Use of the source code by people the operator has allowed to view it is subject to the LICENSE (PolyForm Noncommercial License 1.0.0).

Article 2 (About Beta Testing)

  1. This app is limited to a select group of testers for the purpose of operation verification, function testing, and improvement proposals.
  2. Since this app is in the testing phase, we cannot guarantee the accuracy, safety, or stability of the displayed content.
  3. Usage data collected during the testing period will be used anonymously and statistically for service improvement.

Article 3 (Disclaimer and Compliance with Pharmaceutical Laws)

  1. The information in this app is for general reference only and does not replace the judgment of medical professionals such as doctors, pharmacists, or registered sellers.
  2. The operator assumes no responsibility for any damages arising from actions or judgments made by users based on information from this app.
  3. The operator is not responsible for any disadvantages to users due to app suspension, malfunctions, modifications, or deletion.

Article 4 (Prohibited Activities)

Testers must not engage in the following activities:

  1. Forwarding URLs to others and allowing unauthorized third parties to use the app
  2. Unauthorized access or reverse engineering
  3. Unauthorized publication or reproduction of app content externally
  4. Inputting false information
  5. Misusing the app for commercial purposes
  6. Activities that interfere with app operation
  7. Activities that violate laws or public order and morals

Article 5 (Changes and Termination of Beta Content)

The operator may change, suspend, or terminate the app content without prior notice.

Article 6 (Intellectual Property Rights)

  1. Intellectual property rights such as copyrights, programs, and designs related to this app belong to the operator or rightful owners.
  2. The source code of this app is not public. People the operator has allowed to view it may use, modify, and redistribute it for non-commercial purposes only, under PolyForm Noncommercial License 1.0.0. Commercial use requires the operator's prior written permission.
  3. These terms govern use of this app (the service) and may differ from the source code license terms in the preceding item.
  4. Image assets and medicine data used in this app are subject to separate rights holders or terms of use.

Article 7 (Contact Information)

Please contact us through the following form or email for app issues or inquiries:

Article 8 (Governing Law and Jurisdiction)

These terms shall be interpreted in accordance with Japanese law. Any disputes arising from this app shall be subject to the exclusive jurisdiction of the district court with jurisdiction over the operator's location as the court of first instance.

Effective date: October 29, 2025

Revision history

  • October 29, 2025: Initial publication
  • June 22, 2026: Added intellectual property provisions (non-commercial source code license)
  • October 8, 2026: Changed how Articles 1 and 6 describe the source code license terms, as the source code is no longer public
🔒 Privacy Policy (Beta Version)

Article 1 (Basic Policy)

This app "Chat-based Medicine Consultation Tool" appropriately handles information obtained from testers during the beta testing phase, complying with the Personal Information Protection Act and related laws. We respect tester privacy and strive to provide a safe and trustworthy environment.

Article 2 (Information Collected)

This app may collect the following information for beta testing purposes:

  1. User input information (symptoms, age group, gender, allergies, concomitant medications, etc.)
  2. Usage history, access logs, usage times, error information, etc.
  3. Information when using LINE integration
    • LINE user ID (LINE userId): an identifier that LINE issues for this app. It is different from the "ID" you choose in LINE and from your phone number. We store it as is, without hashing, for the following purposes.
      • To send replies in several parts or send slow replies later (LINE requires this ID as the recipient of messages sent later)
      • So that a pharmacist can send an answer from the admin screen
      • To link conversation records and long-term memory (attribute information and consultation summaries) to the same user, including conversations handed off from LINE to a web browser
      • To obtain your profile, such as your display name, from LINE
    • LINE profile (display name, profile image URL, status message, and language setting): obtained and stored so that operators can tell users apart on the admin screen. If your display name is your real name, that is stored too.
    • Consultation content and its summaries, and attribute information (stored long term so consultations can continue)
    • Short-lived tokens for handing off to a web browser
    • How the LINE user ID and profile are protected:
      • They are stored in the database described in Article 4, item 6 (Neon, data center in Singapore). They are also recorded in operational logs (Google Cloud: 30 days; Amazon Web Services, Tokyo: 7 days), which are deleted automatically when that period ends.
      • Only the operator (including pharmacists who answer from the admin screen) can see them (the admin screen is password-protected). They are not included in what is sent to the external AI businesses or translation services in Article 4.
      • A deletion request in the chat removes consultation memory, attribute information, and past conversation records (the most recent exchanges are kept so the conversation can continue). Other requests for disclosure, correction, or deletion are accepted through the contact in Article 7.
    • Difference from using a web browser: the web user ID is a random number issued by this app and is stored in a browser cookie and in conversation records. It is not linked to IDs of external services such as LINE. For both LINE and web, the record of your consent to this Privacy Policy is stored with a hashed value of the user ID (the ID itself is not kept in the consent record).
  4. Survey and feedback form responses

※As a rule, we do not collect information that directly identifies individuals, such as names, addresses, or phone numbers.

Article 3 (Purpose of Use)

Collected information is used only for the following purposes:

  • To improve app accuracy, fix bugs, and enhance functionality
  • To improve safety and suggestion quality in continued consultations on LINE and elsewhere by referring to past consultation summaries and attribute information
  • To continue a consultation by handing it off to a web browser
  • To analyze test results and create development reports
  • For necessary operational communications (bug reports, improvement requests, etc.)

Article 4 (Third-Party Disclosure and Use of External Services)

  1. The operator will not provide collected information to third parties except in the following cases:
    • When required by law
    • When there is clear consent from the individual
  2. To generate responses to consultations, this app sends input content to the following businesses located in foreign countries and entrusts them with processing. Names and contact details are not sent.
    • OpenAI (United States): used to generate responses, classify consultation content, and search for medicines. We send the consultation text, attributes such as age group, chronic conditions, allergies, and medicines you take, and conversation summaries. This content is not used to train models. It is retained for up to 30 days for abuse monitoring.
    • Alibaba Cloud (Qwen / Singapore): used to generate responses and classify consultation content. We send the same content as to OpenAI. It is not used to train models. It is retained for up to 30 days.
    • Moonshot AI (Kimi / Singapore): used as a backup when the providers above are unavailable. We send the same content as to OpenAI. Under the company's terms, it may be used to improve its services and train its models.
    • TypeSafe (Jev / United States): used to classify consultation content (urgency, type of consultation, etc.). We send your current message and the last few exchanges, with names, phone numbers, and similar information automatically masked. Input is not used to train models. Classification results and statistics may be used to improve the service. No retention period is specified.
  3. We ask for your consent to the above transfers, and to the transfer to DeepL described in paragraph 5, when you start using the app (the above transfers constitute "provision to third parties in foreign countries" under the Act on the Protection of Personal Information).
    • Systems in the recipients' countries: Singapore has a Personal Data Protection Act (PDPA) and a supervisory authority. The United States has no comprehensive federal law; personal information is protected by state and sector-specific laws. Each country also has systems under which the government may require businesses to provide information for investigation or national security purposes. For details, see the Personal Information Protection Commission's survey of personal information protection systems in foreign countries (Singapore, United States (federal); in Japanese).
    • Measures taken by the recipients: Each company sets out restrictions on use for other purposes, security management, breach notification, and other measures in its API terms of use and data processing terms. How sent content is handled is described in the previous paragraph.
  4. Consultation content may include "special care-required personal information" such as medical history and chronic conditions. We collect and send it, with your consent, only to the extent necessary to generate responses. Please do not enter information that can identify you, such as your name, address, or phone number.
  5. In addition to generating AI responses, we send parts of input text or replies to the following services.
    • DeepL (Germany): used to translate replies when you consult in a language other than Japanese. We send the reply; names, phone numbers, email addresses, addresses, and similar information are automatically masked before sending. We use the free version, and text sent may be used to improve DeepL's AI.
    • Google (Cloud Text-to-Speech / United States): used to read replies aloud (only when you use read-aloud). Text sent is not logged.
    • Amazon Web Services (Japan, Tokyo region): used in the test environment for translation, read-aloud, medical term extraction, recommendation re-ranking, and search. We send input text, replies, and operation records, which are handled in accordance with each service's terms.
  6. Consultation records (conversation summaries and attributes) are stored in a database provided by Neon (a US company). The data is located in a data center in Singapore.

Article 5 (Information Management and Deletion)

  1. Collected information is managed in a secure environment with appropriate technical and organizational measures to prevent unauthorized access, leakage, or tampering.
  2. Long-term memory from LINE integration (attribute information, consultation summaries, etc.) is retained for a certain period to support continued consultations and improve safety. Users may request disclosure, correction, or deletion via a deletion request in the chat or through the contact information in Article 7.
  3. When the trial operation ends or the app is discontinued, information that could identify individuals is promptly deleted or anonymized, except where retention is required by law.

Article 6 (Handling of Anonymized Information)

  1. The operator may create "anonymized information" by processing information obtained from users so that individuals cannot be identified.
  2. Anonymized information may be used for statistical processing, service improvement, academic research, and other purposes in a format that cannot identify individuals.
  3. When providing anonymized information to third parties, we maintain a format that cannot be re-identified and implement appropriate security management measures.
  4. When policies regarding the creation and provision of anonymized information change, we will promptly announce them within this policy.

Article 7 (Tester Rights)

Testers can request disclosure, correction, or deletion of their information.

  1. When using LINE integration, you can ask in the chat to delete your consultation memory and attribute information.
  2. For other requests, partial deletion, or disclosure requests, please contact:

Article 8 (Revisions)

This policy may be revised as necessary. Revised content takes effect from the time it is posted on this app. Revision history is listed at the end of this document.

Effective date: October 29, 2025

Revision history

  • October 29, 2025: Initial publication
  • June 22, 2026: Added provisions on LINE integration, long-term memory, deletion requests, and web handoff
  • October 7, 2026: Added to Article 4 the sending of data to, and entrustment of processing to, external AI services (OpenAI, Moonshot AI, Alibaba Cloud) for generating responses
  • October 8, 2026: Added Jev (TypeSafe) to Article 4, and added, for each foreign business, the country, purpose, content sent, and handling, as well as the systems in each country, special care-required personal information, translation and read-aloud services, and where data is stored
  • October 8, 2026: Rewrote Article 2, item 3 (information when using LINE integration) to match actual handling (why the LINE user ID is stored as is and how it is protected, obtaining the LINE profile, and the difference from the web user ID)
Start chat